BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 25824986)

  • 1. Identification of therapeutic targets for breast cancer using biological informatics methods.
    Liu X; Ma Y; Yang W; Wu X; Jiang L; Chen X
    Mol Med Rep; 2015 Aug; 12(2):1789-95. PubMed ID: 25824986
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bioinformatic analysis of computational identified differentially expressed genes in tumor stoma of pregnancy‑associated breast cancer.
    Zhou Q; Sun E; Ling L; Liu X; Zhang M; Yin H; Lu C
    Mol Med Rep; 2017 Sep; 16(3):3345-3350. PubMed ID: 28713995
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular mechanisms of breast cancer metastasis by gene expression profile analysis.
    Zheng T; Wang A; Hu D; Wang Y
    Mol Med Rep; 2017 Oct; 16(4):4671-4677. PubMed ID: 28791367
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Integrated analysis of differentially expressed genes and pathways in triple‑negative breast cancer.
    Peng C; Ma W; Xia W; Zheng W
    Mol Med Rep; 2017 Mar; 15(3):1087-1094. PubMed ID: 28075450
    [TBL] [Abstract][Full Text] [Related]  

  • 5. FN1, SPARC, and SERPINE1 are highly expressed and significantly related to a poor prognosis of gastric adenocarcinoma revealed by microarray and bioinformatics.
    Li L; Zhu Z; Zhao Y; Zhang Q; Wu X; Miao B; Cao J; Fei S
    Sci Rep; 2019 May; 9(1):7827. PubMed ID: 31127138
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of candidate biomarkers and pathways associated with SCLC by bioinformatics analysis.
    Wen P; Chidanguro T; Shi Z; Gu H; Wang N; Wang T; Li Y; Gao J
    Mol Med Rep; 2018 Aug; 18(2):1538-1550. PubMed ID: 29845250
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bioinformatics analyses of significant genes, related pathways and candidate prognostic biomarkers in glioblastoma.
    Zhou L; Tang H; Wang F; Chen L; Ou S; Wu T; Xu J; Guo K
    Mol Med Rep; 2018 Nov; 18(5):4185-4196. PubMed ID: 30132538
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of differentially expressed genes regulated by molecular signature in breast cancer-associated fibroblasts by bioinformatics analysis.
    Vastrad B; Vastrad C; Tengli A; Iliger S
    Arch Gynecol Obstet; 2018 Jan; 297(1):161-183. PubMed ID: 29063236
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of breast cancer hub genes and analysis of prognostic values using integrated bioinformatics analysis.
    Fang E; Zhang X
    Cancer Biomark; 2017 Dec; 21(1):373-381. PubMed ID: 29081411
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of hub genes to regulate breast cancer metastasis to brain by bioinformatics analyses.
    Tang D; Zhao X; Zhang L; Wang Z; Wang C
    J Cell Biochem; 2019 Jun; 120(6):9522-9531. PubMed ID: 30506958
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of prostate cancer hub genes and therapeutic agents using bioinformatics approach.
    Fang E; Zhang X; Wang Q; Wang D
    Cancer Biomark; 2017 Dec; 20(4):553-561. PubMed ID: 28800317
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Integrated bioinformatics analyses identifying potential biomarkers for type 2 diabetes mellitus and breast cancer: In SIK1-ness and health.
    Durrani IA; Bhatti A; John P
    PLoS One; 2023; 18(8):e0289839. PubMed ID: 37556419
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microarray Analysis for Differentially Expressed Genes Between Stromal and Epithelial Cells in Development and Metastasis of Invasive Breast Cancer.
    Wang R; Fu L; Li J; Zhao D; Zhao Y; Yin L
    J Comput Biol; 2020 Dec; 27(12):1631-1643. PubMed ID: 32429691
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Integrated bioinformatics analysis reveals key candidate genes and pathways in breast cancer.
    Wang Y; Zhang Y; Huang Q; Li C
    Mol Med Rep; 2018 Jun; 17(6):8091-8100. PubMed ID: 29693125
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of Potential Biomarkers for Thyroid Cancer Using Bioinformatics Strategy: A Study Based on GEO Datasets.
    Shen Y; Dong S; Liu J; Zhang L; Zhang J; Zhou H; Dong W
    Biomed Res Int; 2020; 2020():9710421. PubMed ID: 32337286
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of key genes involved in tamoxifen-resistant breast cancer using bioinformatics analysis.
    Wang X; Wang S
    Transl Cancer Res; 2021 Dec; 10(12):5246-5257. PubMed ID: 35116374
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Microarray based analysis of gene regulation by mesenchymal stem cells in breast cancer.
    Zhang M; Gao CE; Li WH; Yang Y; Chang L; Dong J; Ren YX; Chen D
    Oncol Lett; 2017 Apr; 13(4):2770-2776. PubMed ID: 28454465
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of candidate target genes of pituitary adenomas based on the DNA microarray.
    Zhou W; Ma CX; Xing YZ; Yan ZY
    Mol Med Rep; 2016 Mar; 13(3):2182-6. PubMed ID: 26782791
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Integrated bioinformatics analysis for the screening of hub genes and therapeutic drugs in ovarian cancer.
    Yang D; He Y; Wu B; Deng Y; Wang N; Li M; Liu Y
    J Ovarian Res; 2020 Jan; 13(1):10. PubMed ID: 31987036
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The identification of key genes and pathways in hepatocellular carcinoma by bioinformatics analysis of high-throughput data.
    Zhang C; Peng L; Zhang Y; Liu Z; Li W; Chen S; Li G
    Med Oncol; 2017 Jun; 34(6):101. PubMed ID: 28432618
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.